Mycosis fungoides diagnosed after exposure to risankizumab for psoriasis

Fahmy, L. M., Schreidah, C. M., Lapolla, B. A., Magro, C. M., & Geskin, L. J. (2023). Mycosis fungoides diagnosed after exposure to risankizumab for psoriasis. JAAD Case Reports, 41, 85–89. https://doi.org/10.1016/j.jdcr.2023.08.049
Authors:
Lauren M. Fahmy
Celine M. Schreidah
Brigit A. Lapolla
Cynthia M. Magro
Larisa J. Geskin
Affiliated Authors:
Lauren M. Fahmy
Celine M. Schreidah
Brigit A. Lapolla
Larisa J. Geskin
Columbia Affiliation:
Subjects:
Classification and Treatment of Cutaneous Lymphomas (OpenAlex Topic)
Reciprocal Development of TH17 and Treg Cells (OpenAlex Topic)
Pathogenesis and Treatment of Pemphigoid Diseases (OpenAlex Topic)
Author Keywords:
biologic
cytokine blocker
interleukin-23
mycosis fungoides
psoriasis
risankizumab
elink
Publication Type:
Article
Unique ID:
10.1016/j.jdcr.2023.08.049
PMID:
37916040
DOI:
10.1016/j.jdcr.2023.08.049
Journal:
JAAD Case Reports
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View Scopus Record

Record Created: